14 results
GVIRF 2023 Presentation
Keynote presentation by the Director, National Institute of Infectious Diseases and Acting Director, NIH Korea
Sustained Vaccination Coverage during the Coronavirus Disease 2019 Epidemic in the Republic of Korea
Amid the COVID-19 pandemic, vaccination coverage may decline due to limited accessibility to healthcare. This study assessed the impact of the COVID-19 pandemic on vaccination coverage and the...
The public health benefits of vaccination are clear. The World Health Organization estimates that, in 2008, more than 2.5 million deaths were prevented by vaccination.1 Immunization programmes have...
The Developing Countries Vaccine Manufacturers Network (DCVMN) assembled high-profile leaders from global health organisations and vaccine manufactures for its 16th Annual General Meeting to work...
Since the beginning of 2014, the Republic of Korea has experienced a resurgence of measles cases. Among the 220 cases confirmed as measles during epidemiological weeks 1-20 (December 29, 2013 to May...
Tremendous progress has been made globally to reduce the contribution of measles to the burden of childhood deaths and measles cases have dramatically decreased with increased two dose...
Introduction: Origins and Definitions
International cooperation for purposes of infectious and tropical disease control goes back to at least the 14th century, when early concepts of quarantine...
Although pneumococcal vaccines had been recommended for the elderly population in South Korea for a considerable period of time, the coverage has been well below the optimal level. To increase the...
Following the implementation of national measles elimination plan in Korea, the elimination was declared in 2006. In order to sustain the elimination, high population immunity should be continuously...
This study suggests that vaccine storage practices and awareness are inadequate, but can be partially improved by providing relevant education. Repetitive education and policy-making are required to...
Triangulation of results from two methods captured a richer story behind vaccine adoption decisions for hepatitis A. The discrepancy between policymakers’ beliefs and existing data suggest a...
This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A...
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...